RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 49 filers reported holding RECRO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,380,410 | +156690.8% | 3,073,100 | +4.1% | 1.16% | +34.9% |
| Q1 2023 | $2,156 | -66.4% | 2,953,100 | -31.5% | 0.86% | -67.4% |
| Q4 2022 | $6,425 | -99.9% | 4,312,400 | +34.4% | 2.64% | -12.0% |
| Q3 2022 | $5,231,000 | +103.8% | 3,209,400 | -0.6% | 3.00% | +105.5% |
| Q2 2022 | $2,567,000 | -65.7% | 3,229,500 | -22.4% | 1.46% | -53.6% |
| Q1 2022 | $7,493,000 | +4.2% | 4,162,500 | -1.0% | 3.15% | +29.0% |
| Q4 2021 | $7,189,000 | +0.6% | 4,204,000 | +21.2% | 2.44% | -8.0% |
| Q3 2021 | $7,143,000 | +11.9% | 3,467,600 | +25.5% | 2.66% | +14.8% |
| Q2 2021 | $6,383,000 | +148.7% | 2,763,400 | -14.4% | 2.32% | +58.3% |
| Q2 2020 | $2,567,000 | – | 3,229,500 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |